beta-Adrenergic receptor polymorphisms: relationship to the beta-agonist controversy and clinical implications.

Abstract excerpt

Aspects of the 'beta-agonist controversy' have recently re-emerged with the publication of data implicating the long-acting beta-agonist salmeterol in increased mortality from asthma. The reasons underlying the adverse effects of beta2-agonists as a class are unclear. Polymorphisms of the beta2 adrenoceptor (ADRB2), notably the variant associated with an arginine moiety at position 16 of the ADRB2 protein result...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Adrenergic beta-2 Receptor Agonists
• Share to Adrenergic beta-Agonists